Area of research
Surgery · Pulmonary and Respiratory Medicine
Research interest
Research interests include Esophageal and GI Pathology, Eosinophilic Esophagitis, Gastric Cancer Management and Outcomes, and Gastroesophageal reflux and treatments.
The 1st EoETALY Consensus on the Diagnosis and Management of Eosinophilic Esophagitis – Definition, Clinical Presentation and Diagnosis
The 1st EoETALY Consensus on the Diagnosis and Management of Eosinophilic Esophagitis–Current Treatment and Monitoring
Swallowed topical corticosteroids for eosinophilic esophagitis: Utilization and real‐world efficacy from the EoE CONNECT registry
Eosinophils, Eosinophilic Gastrointestinal Diseases, and Inflammatory Bowel Disease: A Critical Review
Combination of Mucosa-Exposure Device and Computer-Aided Detection for Adenoma Detection During Colonoscopy: A Randomized Trial
Differences between childhood- and adulthood-onset eosinophilic esophagitis: An analysis from the EoE connect registry
EoE CONNECT, the European Registry of Clinical, Environmental, and Genetic Determinants in Eosinophilic Esophagitis: rationale, design, and study protocol of a large-scale epidemiological study in Europe
Diagnostic delay and misdiagnosis in eosinophilic oesophagitis
Prevention Strategies for Esophageal Cancer—An Expert Review
Efficacy of Real-Time Computer-Aided Detection of Colorectal Neoplasia in a Randomized Trial
Undefined/non-malignant hepatic nodules are associated with early occurrence of HCC in DAA-treated patients with HCV-related cirrhosis
Esophageal reflux hypersensitivity: Non-GERD or still GERD?
Advancements in the use of manometry and impedance testing for esophageal functional disorders
Proton pump inhibitors: use and misuse in the clinical setting
A safety review of proton pump inhibitors to treat acid-related digestive diseases
A review of pharmacotherapy for treating gastroesophageal reflux disease (GERD)
Application of the Intermediate-Stage Subclassification to Patients With Untreated Hepatocellular Carcinoma
Adalimumab trough serum levels and anti-adalimumab antibodies in the long-term clinical outcome of patients with Crohn’s disease
Vonoprazan for treatment of gastroesophageal reflux: pharmacodynamic and pharmacokinetic considerations